BioKDE: Biomedical Knowledge Discovery Engine

Contact Us Login
Sorted by:  
Results by Year
Article Type
Publication date
  473,190 results (0.017 seconds)
1
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy.
Zeina N Al-Mahayri,  George P Patrinos,  Bassam R Ali.
Front Pharmacol, 2020 May 01; 11. PMID: 32351390     Free PMC article
Review.
2
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
J Cortes, V Calvo, +15 authors, J Baselga.
Ann Oncol, 2011 Oct 07; 23(5). PMID: 21976387
Systematic Review. Review.
3
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
J Cortes, V Calvo, +15 authors, J Baselga.
Ann Oncol, 2019 Jan 10; 30(7). PMID: 30624662
4
Scalp cooling and hair loss during breast cancer chemotherapy.
Vicki Brower.
Lancet Oncol, 2017 Feb 28; 18(4). PMID: 28238594
5
A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Michael D Stubblefield,  Margaret L McNeely,  Catherine M Alfano,  Deborah K Mayer.
Cancer, 2012 Apr 18; 118(8 Suppl). PMID: 22488699
Review.
6
Emerging therapeutic options for breast cancer chemotherapy during pregnancy.
O Mir, P Berveiller, +4 authors, F Goldwasser.
Ann Oncol, 2007 Oct 09; 19(4). PMID: 17921242
Review.
7
Fatty acids: Adiposity and breast cancer chemotherapy, a bad synergy?
Ilze Mentoor,  A-M Engelbrecht,  Theo Nell.
Prostaglandins Leukot Essent Fatty Acids, 2018 Dec 17; 140. PMID: 30553399
Review.
8
Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
Sharon Marsh,  Geoffrey Liu.
Adv Drug Deliv Rev, 2008 Dec 23; 61(5). PMID: 19100797
Review.
9
Patterns and predictors of exercise behavior during 24 months of follow-up after a supervised exercise program during breast cancer chemotherapy.
Ki-Yong An, Dong-Woo Kang, +6 authors, Kerry S Courneya.
Int J Behav Nutr Phys Act, 2020 Feb 16; 17(1). PMID: 32059728     Free PMC article
10
Mitochondria-Specific Anticancer Drug Delivery Based on Reduction-Activated Polyprodrug for Enhancing the Therapeutic Effect of Breast Cancer Chemotherapy.
Yajun Wang, Tian Zhang, +7 authors, Zhigang Xu.
ACS Appl Mater Interfaces, 2019 Jul 23; 11(32). PMID: 31329411
11
Reversing Multidrug Resistance by Multiplexed Gene Silencing for Enhanced Breast Cancer Chemotherapy.
Yanli Li, Xiaonan Gao, +4 authors, Bo Tang.
ACS Appl Mater Interfaces, 2018 Apr 18; 10(18). PMID: 29663807
12
Retinal-conjugated pH-sensitive micelles induce tumor senescence for boosting breast cancer chemotherapy.
Yijuan Zhang, Ping Li, +6 authors, Yifan Ma.
Biomaterials, 2016 Jan 18; 83. PMID: 26774567
13
Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
Heather Greenlee, Alfred I Neugut, +12 authors, Dawn L Hershman.
JAMA Oncol, 2016 Jun 01; 2(9). PMID: 27243607     Free PMC article
14
Systemic treatment for breast cancer: chemotherapy and biotherapy agents.
Laura Bourdeanu,  Ellen A Liu.
Semin Oncol Nurs, 2015 May 09; 31(2). PMID: 25951744
Review.
15
[Medical treatment of breast cancer: chemotherapy and tailored therapy].
Florence Dalenc.
Rev Prat, 2014 Mar 04; 63(10). PMID: 24579340
Review.
16
Effectiveness of a Smartphone Application as a Support Tool for Patients Undergoing Breast Cancer Chemotherapy: A Randomized Controlled Trial.
Satoko Handa, Hiromi Okuyama, +2 authors, Yasuhisa Kato.
Clin Breast Cancer, 2020 Mar 24; 20(3). PMID: 32201165
17
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.
N Kluger, W Jacot, +6 authors, D Bessis.
Ann Oncol, 2012 May 11; 23(11). PMID: 22571858
18
Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901.
Jeanne S Mandelblatt, Leigh Anne Faul, +7 authors, Harvey J Cohen.
J Clin Oncol, 2012 May 23; 30(21). PMID: 22614985     Free PMC article
19
Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer.
Fengrui Xu,  Zefei Jiang.
Ann Transl Med, 2020 Mar 17; 8(4). PMID: 32176221     Free PMC article
20
Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer.
Fengrui Xu,  Zefei Jiang.
Ann Transl Med, 2020 Jun 23; 8(10). PMID: 32566595     Free PMC article
1 2 3 4 5 6 7 8 9 10 Next